Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.
about
Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate CancerGenomic and Histopathological Tissue Biomarkers That Predict Radiotherapy Response in Localised Prostate CancerThe path to routine use of genomic biomarkers in the cancer clinicMicroRNA in radiotherapy: miRage or miRador?Integrative clinical genomics of advanced prostate cancer.Current and Evolving Methods to Visualize Biological Data in Cancer Research.The Molecular Taxonomy of Primary Prostate Cancer.Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohortImproved Method to Stratify Elderly Patients With Cancer at Risk for Competing EventsIntegration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort studySPOP mutation leads to genomic instability in prostate cancer.Personalized radiotherapy: concepts, biomarkers and trial designTargeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer.Translational and clinical implications of the genetic landscape of prostate cancer.Biomarkers for prostate cancer: present challenges and future opportunities.Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.Morning breathing exercises prolong lifespan by improving hyperventilation in people living with respiratory cancer.Clinically relevant genetic characterization of prostate tumors: how close are we to the goal?Synergistic action of image-guided radiotherapy and androgen deprivation therapy.Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting.Nuclear Shape and Architecture in Benign Fields Predict Biochemical Recurrence in Prostate Cancer Patients Following Radical Prostatectomy: Preliminary Findings.DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer.Hypoxia-activated prodrugs: paths forward in the era of personalised medicine.Clinical variability and molecular heterogeneity in prostate cancer.Personalized treatment of prostate cancer: better knowledge of the patient, the disease and the medicine.Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.The changing paradigm of tumour response to irradiation.Homeostasis Back and Forth: An Ecoevolutionary Perspective of Cancer.Mining Human Prostate Cancer Datasets: The "camcAPP" Shiny App.Beyond Seed and Soil: Understanding and Targeting Metastatic Prostate Cancer; Report From the 2016 Coffey-Holden Prostate Cancer Academy Meeting.Clinical and molecular rationale to retain the cancer descriptor for Gleason score 6 disease.Revisiting Seed and Soil: Examining the Primary Tumor and Cancer Cell Foraging in Metastasis.Predictors of early androgen deprivation treatment failure in prostate cancer with bone metastases.A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: a retrospective cohort study.Hypoxia on the Expression of Hepatoma Upregulated Protein in Prostate Cancer Cells.Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy SpecimensChanges in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial.Androgen receptor profiling predicts prostate cancer outcome.Mitochondrial mutations drive prostate cancer aggression.Long non-coding RNA urothelial carcinoma associated 1 (UCA1) mediates radiation response in prostate cancer.
P2860
Q26766638-76359B08-63EE-4E06-80B1-01B3FB72A92DQ26778586-E932C711-BBA4-46B1-8B5E-A25513E77DF3Q26782733-6D997795-1AC8-43EE-B724-B4DC925C8F4AQ27025405-A367BA13-54E7-492B-AD45-D65E48FFC42FQ27853170-47EFA201-5538-44A5-B2E5-B4F640E7CA5EQ31104342-238CD7C8-2864-4881-9800-682392A4AA56Q34674332-533DD58D-AE71-47CF-84B5-84DD435693D1Q35909631-30411AC6-CF25-4571-98D3-BAB25AB6D66FQ35925651-41D98726-59CC-4753-9563-E106FBF87834Q36106271-F1EDD1AA-A38B-46BA-84B1-759E2DFCD35AQ36210354-A49B2CC5-1AFE-4AFB-AC82-4737FD499841Q36235704-FAC20033-2F9F-4BC8-9640-64848D3551D5Q37060938-FD8A86B5-7BFF-4A5B-8EFB-2F5161566FA8Q37270512-45A3B99A-6540-43A3-A37A-98AA3FA29C4CQ37474443-AA90234F-32C8-416D-A87C-0BD430B58362Q37581351-6076C803-2843-45E7-A57D-301998AED194Q37606362-6712F81D-DF11-4C37-A0EF-F83B4A3A103EQ38356863-7FE6C6AE-CD0A-4F4F-A703-74AFCD8DB502Q38387844-443CE0B2-C6D1-453F-851C-5FE3B6E71498Q38610286-01CCBB14-7004-4190-AB7E-8BBB97E55A3CQ38650310-3F5A3DD2-B15C-45B9-8F6E-FBAE925A79AFQ38774228-B953E499-DB63-47CC-AFF0-186D96DBE11CQ38806173-B1EB362B-68A9-4EA5-9C14-B0963580E4B1Q38808811-A98DEBA7-1486-42A5-ACFE-6B55144F81D3Q38841014-8401568F-89E2-4D83-959A-CE73920CF0C8Q38855675-1CADBF3E-C92D-42A6-9BB3-835C56401975Q38896870-D30FD2A3-7F0D-463C-AE09-03933FD6F0D9Q38910371-A72617EC-2259-445E-89FE-D65A5DD2C2B8Q38912431-DFF250CF-6115-49D3-B8C3-7CD75521D7FEQ38966736-832553F9-FD38-4639-9FD9-EFC517F8DD71Q39023426-653A3CA8-D5CB-453E-909F-6A4F9B3982DDQ39139734-5F86DAFC-40B6-4BCE-8428-B1472377B23DQ39222023-18C13369-8809-47FE-8FF7-1F51FE001561Q39581362-DA60939D-4D85-45BF-8BFD-38D352C08B5AQ39631128-2F4C0531-9161-4FE7-A394-6D2862B25508Q39946238-17276C53-5297-4F70-A078-9A81D5D87936Q40112666-00675BC9-5B83-4F34-892C-089A98C78310Q40493333-722B4359-0DF7-4A81-AB42-D0B2BCCBF68DQ41689819-F7C8A9C2-5F37-454E-BE63-CE03366A58DEQ42182491-3FE58807-FD4E-45D4-A59D-C3A59FDD6544
P2860
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Tumour genomic and microenviro ...... a retrospective cohort study.
@en
type
label
Tumour genomic and microenviro ...... a retrospective cohort study.
@en
prefLabel
Tumour genomic and microenviro ...... a retrospective cohort study.
@en
P2093
P50
P1433
P1476
Tumour genomic and microenviro ...... a retrospective cohort study.
@en
P2093
Adrian S Ishkanian
Alan Dal Pra
Alastair D Lamb
Anne Y Warren
Chad A Malloff
Cherry L Have
Christine P'ng
Cindy Q Yao
Colin C Collins
Colin Cooper
P304
P356
10.1016/S1470-2045(14)71021-6
P407
P50
P577
2014-11-13T00:00:00Z